Familial non-autoimmune hyperthyroidism in family members across four generations due to a novel disease-causing variant in the thyrotropin receptor gene
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Kero J, Ahmed K, Wettschureck N, Tunaru S, Wintermantel T, Greiner E, et al. Thyrocyte-specific Gq/ G11 deficiency impairs thyroid function and prevents goiter development. J Clin Invest. 2007; 117(9): 2399-2407.KeroJAhmedKWettschureckNTunaruSWintermantelTGreinerEet alThyrocyte-specific Gq/ G11 deficiency impairs thyroid function and prevents goiter development200711792399240710.1172/JCI30380193749817694176Search in Google Scholar
Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, Schvartz C, et al. Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism. Nat Genet. 1994; 7(3): 396-401.DuprezLParmaJVanSande JAllgeierALeclèreJSchvartzCet alGermline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism19947339640110.1038/ng0794-3967920658Search in Google Scholar
Kopp P, Van Sande J, Parma J, Duprez L, Gerber H, Joss E, et al. Congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N Engl J Med. 1995; 332(3): 150-154.KoppPVanSande JParmaJDuprezLGerberHJossEet alCongenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene1995332315015410.1056/NEJM1995011933203047800007Search in Google Scholar
Stephenson A, Lau L, Eszlinger M, Paschke R. The thyroid stimulating hormone receptor mutation database update. Thyroid. 2020; 30(6): 931-935.StephensonALauLEszlingerMPaschkeRThe thyroid stimulating hormone receptor mutation database update202030693193510.1089/thy.2019.080732111150Search in Google Scholar
Paschke R, Niedziela M, Vaidya B, Persani L, Rapoport B, Leclere J. 2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations. Eur Thyroid J. 2012; 1(3): 142-147.PaschkeRNiedzielaMVaidyaBPersaniLRapoportBLeclereJ2012 European thyroid association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations20121314214710.1159/000342982382148124783013Search in Google Scholar
Ferraz C, Paschke R. Inheritable and sporadic non-autoimmune hyperthyroidism. Best Pract Res Clin Endocrinol Metab [Internet]. 2017; 31(2): 265-275. (Available at http://dx.doi.org/10.1016/j.beem.2017.04.005.)FerrazCPaschkeRInheritable and sporadic non-autoimmune hyperthyroidism2017312265275Available athttp://dx.doi.org/10.1016/j.beem.2017.04.005.)10.1016/j.beem.2017.04.00528648513Search in Google Scholar
Gozu HI, Lublinghoff J, Bircan R, Paschke R. Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism. Mol Cell Endocrinol. 2010; 322(1-2): 125-134.GozuHILublinghoffJBircanRPaschkeRGenetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism20103221-212513410.1016/j.mce.2010.02.00120138963Search in Google Scholar
Führer D. Constitutive TSH receptor activation as a hallmark of thyroid autonomy. Endocrine. 2020; 68(2): 274-278.FührerDConstitutive TSH receptor activation as a hallmark of thyroid autonomy202068227427810.1007/s12020-020-02270-z726678932303903Search in Google Scholar
Human Gene Mutation Database (HGMD®) (http://www.hgmd.cf.ac.uk/)http://www.hgmd.cf.ac.uk/)Search in Google Scholar
Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B, Hart J, et al. ClinVar: Improvements to accessing data. Nucleic Acids Res. 2020; 48(D1): D835-D844. doi: 10.1093/nar/gkz972.LandrumMJChitipirallaSBrownGRChenCGuBHartJet alClinVar: Improvements to accessing data202048D1D835D84410.1093/nar/gkz972694304031777943Open DOISearch in Google Scholar
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809): 434-443. doi: 10.1038/s41586- 020-2308-7. Epub 2020 May 27.KarczewskiKJFrancioliLCTiaoGCummingsBBAlföldiJWangQet alThe mutational constraint spectrum quantified from variation in 141,456 humans2020581780943444310.1038/s41586-020-2308-7.Epub2020May27Open DOISearch in Google Scholar
Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31(13): 3812-3814.NgPCHenikoffSSIFT: Predicting amino acid changes that affect protein function200331133812381410.1093/nar/gkg50916891612824425Search in Google Scholar
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4):248-249.AdzhubeiIASchmidtSPeshkinLRamenskyVEGerasimovaABorkPet alA method and server for predicting damaging missense mutations20107424824910.1038/nmeth0410-248285588920354512Search in Google Scholar
Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: Mutation prediction for the deep-sequencing age. Nat Methods. 2014; 11(4): 361-362.SchwarzJMCooperDNSchuelkeMSeelowDMutationTaster2: Mutation prediction for the deep-sequencing age201411436136210.1038/nmeth.289024681721Search in Google Scholar
Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: Predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019; 47(D1): D886-D894.RentzschPWittenDCooperGMShendureJKircherMCADD: Predicting the deleteriousness of variants throughout the human genome201947D1D886D89410.1093/nar/gky1016632389230371827Search in Google Scholar
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5): 405-424.RichardsSAzizNBaleSBickDDasSGastier-FosterJet alStandards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology201517540542410.1038/gim.2015.30454475325741868Search in Google Scholar
Fuhrer D, Warner J, Sequeira M, Paschke R, Gregory J, Ludgate M. Novel TSHR germline mutation (Met463 Val) masquerading as Graves’ disease in a large Welsh kindred with hyperthyroidism. Thyroid. 2000; 10(12): 1035-1041.FuhrerDWarnerJSequeiraMPaschkeRGregoryJLudgateMNovel TSHR germline mutation (Met463 Val) masquerading as Graves’ disease in a large Welsh kindred with hyperthyroidism200010121035104110.1089/thy.2000.10.103511201847Search in Google Scholar
De Roux N, Polak M, Couet J, Leger J, Czernichow P, Milgrom E, et al. A neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyper-thyroidism. J Clin Endocrinol Metab. 1996; 81(6): 2023-2026.DeRoux NPolakMCouetJLegerJCzernichowPMilgromEet alA neomutation of the thyroid-stimulating hormone receptor in a severe neonatal hyper-thyroidism199681620232026Search in Google Scholar
Lavard L, Sehested A, Jacobsen BB, Muller J, Perrild H, Feldt-Rasmussen U, et al. Long-term follow-up of an infant with thyrotoxicosis due to germline mutation of the TSH receptor gene (Met453Thr). Horm Res. 1999; 51(1): 43-46.LavardLSehestedAJacobsenBBMullerJPerrildHFeldt-RasmussenUet alLong-term follow-up of an infant with thyrotoxicosis due to germline mutation of the TSH receptor gene (Met453Thr)1999511434610.1159/00002331210095169Search in Google Scholar
Nakamura A, Morikawa S, Aoyagi H, Ishizu K, Tajima T. A Japanese family with nonautoimmune hyperthyroidism caused by a novel heterozygous thyrotropin receptor gene mutation. Pediatr Res. 2014; 75(6): 749-753.NakamuraAMorikawaSAoyagiHIshizuKTajimaTA Japanese family with nonautoimmune hyperthyroidism caused by a novel heterozygous thyrotropin receptor gene mutation201475674975310.1038/pr.2014.3424608569Search in Google Scholar
Supornsilchai V, Sahakitrungruang T, Wongjitrat N, Wacharasindhu S, Suphapeetiporn K, Shotelersuk V. Expanding clinical spectrum of non-autoimmune hyperthyroidism due to an activating germline mutation, p.M453 T, in the thyrotropin receptor gene. Clin Endocrinol (Oxf). 2009; 70(4): 623-628.SupornsilchaiVSahakitrungruangTWongjitratNWacharasindhuSSuphapeetipornKShotelersukVExpanding clinical spectrum of non-autoimmune hyperthyroidism due to an activating germline mutation, p.M453 T, in the thyrotropin receptor gene200970462362810.1111/j.1365-2265.2008.03367.x18681856Search in Google Scholar
Lueblinghoff J, Mueller S, Sontheimer J, Paschke R. Lack of consistent association of thyrotropin receptor mutations in vitro activity with the clinical course of patients with sporadic non-autoimmune hyperthyroidism. J Endocrinol Invest. 2010; 33(4): 228-233.LueblinghoffJMuellerSSontheimerJPaschkeRLack of consistent association of thyrotropin receptor mutations in vitro activity with the clinical course of patients with sporadic non-autoimmune hyperthyroidism201033422823310.1007/BF0334578419636218Search in Google Scholar
Quellari M, Desroches A, Beau I, Beaudeux E, Misrahi M. Role of cleavage and shedding in human thyrotropin receptor function and trafficking. Eur J Biochem. 2003; 270(17): 3486-3497.QuellariMDesrochesABeauIBeaudeuxEMisrahiMRole of cleavage and shedding in human thyrotropin receptor function and trafficking2003270173486349710.1046/j.1432-1033.2003.03718.x12919313Search in Google Scholar
Osuna PM, Udovcic M, Sharma MD. Hyperthyroidism and the heart. Methodist DeBakey Cardiovasc J. 2017; 13(2): 60-63.OsunaPMUdovcicMSharmaMDHyperthyroidism and the heart2017132606310.14797/mdcj-13-2-60551268028740583Search in Google Scholar
Mitchell JE, Hellkamp AS, Mark DB, Anderson J, Johnson GW, Poole JE, et al. Thyroid function in heart failure and impact on mortality. JACC Hear Fail. 2013; 1(1): 48-55.MitchellJEHellkampASMarkDBAndersonJJohnsonGWPooleJEet alThyroid function in heart failure and impact on mortality201311485510.1016/j.jchf.2012.10.004380399924159562Search in Google Scholar